This report on drug abuse testing/screening market studies various test and location types. For decades, drug of abuse test samples were transferred to laboratories with results returned days or even weeks later. More recently, point-of-collection (POC) testing became omnipresent, permitting detection of some drugs and/or their metabolites within minutes of collection.
The global in-vitro diagnostics (IVD) market has considerably evolved over the past decade with the introduction of innovative diagnosis options. Major factors contributing to the growth of in-vitro diagnostics market include growing incidence of chronic diseases, aging population and growing demand for point-of-care testing. Advancements in the field of genomics and proteomics, introduction of condition-specific markers and development of healthcare infrastructure in emerging economies create future prospects for the market.
This report on point-of-care diagnostics / testing (POCT) market studies various products and end-users market. POCT is considered as one of the most affordable technologies of global diagnostics market, and development in POCT technologies over period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts the factors assisting the growth of POC diagnostics market are several government initiatives have aided in the development of innovative outpatient care models, to minimize hospital stays and rapidly increasing demand for home healthcare globally.
This report on global sleep apnea devices market studies the major trends, market size and forecast, and competition analysis of sleep apnea devices industry. The global sleep apnea devices market is witnessing fair growth attributed by technological development in the features of both diagnostic and therapeutic devices. Alarming reporting of sleep disorders, rising life-style related disorders, and the gradual growth in awareness about sleep disorders and their consequent effect on overall health greatly contribute to the growth of sleep apnea devices market.
The worldwide biomarkers market is predicted to grow at 12.5% by 2033. Growing expenditure on health care and research & development activities plus enhanced utility of biomarkers for diagnostics are predicted to stimulate the growth of the global biomarkers market. The growth and expansion of the industry will also be supported by the low prices of clinical trials in emerging nations and new initiatives taken by the firms who are into the biomarker research business.
The global market for diagnostic testing is expected to surpass US $350 billion by 2030, expanding at a CAGR of 9% from 2023 to 2030.
Diagnostic tests are medical examinations performed to aid in the recognition or diagnosis of any disease. These tests are crucial for the management, surveillance, and prevention of any disease. These tests increase patient care, customer security, and healthcare expenditures. According to the study Non-communicable Illnesses Important Statistics from the World Health Organization (WHO), chronic diseases will be responsible for approximately 41 million deaths annually by April 2021, or 71 percent of all deaths worldwide. Hence, diagnostic tests have proved beneficial in the prevention, identification, and diagnosis of disease, as well as in the management of chronic sickness situations. By detecting individual risk factors and early warning signs, clinical diagnostics create new opportunities for early prevention and intervention. Thus, it is projected that the industry as a whole would continue to expand as the prevalence of chronic diseases rises.
The industry is expected to be driven by the increasing popularity of decentralized healthcare systems. In addition, it is predicted that the market would expand during the forecast period as a result of leading market players' adoption of new innovations and technical advancements in the sector. As a result of these reasons, the market for point-of-care diagnostics is predicted to expand in the future years. The aging of the world's population increases the likelihood of contracting a variety of diseases, including diabetes, cancer, cardiovascular disease, obesity, and neurological disorders. The United Nations projects that by 2020, 727 million people worldwide would be 65 or older. In addition, it is estimated that by 2050, there will be more than 1.5 billion individuals aged 80 and older, which is twice as many as there are today. The predicted growth in the global elderly population during the forecast period is likely to have a substantial impact on the market.
Acute Market Reports, a market research and consulting company remains the best choice for industry participants in the diagnostics domain. Acute Market Reports' clients gain from our forward-thinking research technique, which aids in the development of well-informed business decisions. With the help of our extensive network of business partners, we are able to offer innovative strategic research solutions to our global clients.
